Article Information
vol. 11 no. 477
- Received for publication April 5, 2018
- Resubmitted October 12, 2018
- Accepted for publication December 18, 2018
- .
Author Information
- Matthew T. Wolf1,2,3,
- Sudipto Ganguly2,4,
- Tony L. Wang1,5,
- Christopher W. Anderson6,
- Kaitlyn Sadtler7,8,
- Radhika Narain1,5,
- Christopher Cherry1,5,
- Alexis J. Parrillo1,5,
- Benjamin V. Park9,
- Guannan Wang4,
- Fan Pan2,4,
- Saraswati Sukumar4,
- Drew M. Pardoll2,4 and
- Jennifer H. Elisseeff1,2,3,5,*
- 1Translational Tissue Engineering Center, Baltimore, MD 21231, USA.
- 2Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD 21287, USA.
- 3Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- 4Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- 5Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
- 6Department of Experimental Pathology, Yale University School of Medicine, New Haven, CT 06511, USA.
- 7David H. Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- 8Department of Anesthesiology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 9University of Illinois College of Medicine, Chicago, IL 60612, USA.
- ↵*Corresponding author. Email: jhe{at}jhu.edu